Confirmation of names for influenza strains

The Medicines Evaluation Board (MEB) has confirmed the Dutch translation for the active substances for influenza strains for the coming season 2017/2018.

Marketing authorisation holders are obliged to use the Dutch translation. The aim is to achieve a uniform listing of the active substances in the Netherlands.

The Committee for Medicinal Products for Human Use (CHMP) confirmed the strains for the 2017/2018 season during a meeting in April 2017. Marketing authorisation holders are requested to use the translation list in the product information.